Disc Medicine Opco Inc reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 22.78 million compared to USD 9.85 million a year ago. Basic loss per share from continuing operations was USD 1.2 compared to USD 10.67 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.52 USD | -2.86% | -11.66% | -54.09% |
Apr. 08 | Stifel Raises Price Target on Disc Medicine to $73 From $71, Keeps Buy Rating | MT |
Apr. 02 | Leerink Partners Cuts Price Target on Disc Medicine to $65 From $77, Keeps Outperform Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-54.09% | 655M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.07% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- IRON Stock
- News Disc Medicine, Inc.
- Disc Medicine Opco Inc Reports Earnings Results for the First Quarter Ended March 31, 2023